Genomatica and Versalis deepen their strategic partnership by creating a joint venture for bio-based butadiene. Genomatica CEO Christophe Schilling is pictured in top row, third from the right. Versalis CEO Daniele Ferrari is pictured in top row, third from the left.
Genomatica and Versalis deepen their strategic partnership by creating a joint venture for bio-based butadiene. Genomatica CEO Christophe Schilling is pictured in top row, third from the right. Versalis CEO Daniele Ferrari is pictured in top row, third from the left.